Picture of Daiichi Sankyo Co logo

4568 Daiichi Sankyo Co Share Price

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Momentum

Relative Strength (%)
1m-13.96%
3m-18.94%
6m-39.82%
1yr-52.91%
Volume Change (%)
10d/3m+16.88%
Price vs... (%)
52w High-38.39%
50d MA-8.31%
200d MA-22.58%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)13.73
PEG Ratio (f)0.62
EPS Growth (f)28.4%
Dividend Yield (f)3.48%
Valuation (ttm)IndustryMarket
Price to Book Value2.81
Price to Tang. Book3.53
Price to Free Cashflown/a
Price to Sales2.21
EV to EBITDA14.45

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital7.34%
Return on Equity15.81%
Operating Margin10.79%

Financial Summary

Year End 31st MarUnit202220232024202520262027E2028ECAGR / Avg
Total Revenue¥m1,044,8921,278,4781,601,6881,886,2562,123,0452,381,7052,556,57517.14%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-8.58+66.87+79.15+49.21-8.73+31.67+11.2n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202731st Mar 2028
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2027 / 2028

Blurred out image of Daiichi Sankyo Co EPS forecast chart

Profile Summary

Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.

Directors

Last Annual
March 31st, 2026
Last Interim
March 31st, 2026
Incorporated
September 28th, 2005
Public Since
September 28th, 2005
No. of Employees
19,765
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
1,819,653,230

4568 Share Price Performance

Latest News for 4568

Upcoming Events for 4568

Daiichi Sankyo Co Ltd Annual Shareholders Meeting

Q1 2027 Daiichi Sankyo Co Ltd Earnings Release

Dividend For 4568.T - 50.0000 JPY

Q2 2027 Daiichi Sankyo Co Ltd Earnings Release

Similar to 4568

Picture of Astellas Pharma logo

Astellas Pharma

jp flag iconTokyo Stock Exchange

Picture of Astena Holdings Co logo

Astena Holdings Co

jp flag iconTokyo Stock Exchange

Picture of CanBas Co logo

CanBas Co

jp flag iconTokyo Stock Exchange

Picture of CellSeed logo

CellSeed

jp flag iconTokyo Stock Exchange

FAQ